Skip to content
Sunday, February 22, 2026
  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters

Health

  • Business
  • Health

Corebridge drops as AIG looks to sell down stake

The Cheap InvestorJune 6, 2023June 6, 20230

NEW YORK (Reuters) – Shares of retirement services provider Corebridge Financial fell more than 6% on Tuesday as parent American…

  • Business
  • Europe

Cancer vaccines poised to unlock ‘new treatment paradigm’ with Merck/Moderna data

The Cheap InvestorJune 5, 2023June 5, 20230

By Julie Steenhuysen CHICAGO (Reuters) – Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the…

  • Business
  • Economy

Roche looking to sell or shut down California biologic drug plant

The Cheap InvestorJune 5, 2023June 5, 20230

(This May 31 story has been corrected to fix the spelling of executive’s name to Teresa, not Theresa, in paragraph…

  • Health
  • Top News

Texas seeks to bolster $1.8 billion fraud claim against Planned Parenthood

The Cheap InvestorJune 5, 2023June 5, 20230

By Brendan Pierson (Reuters) – Texas and an anonymous anti-abortion activist made a joint court filing over the weekend, urging…

  • Economy
  • Health

Colombia’s lower house freezes reform debates amid voice memo scandal

The Cheap InvestorJune 5, 2023June 5, 20230

By Nelson Bocanegra BOGOTA (Reuters) – Colombia’s lower house on Monday said it would freeze debates on government-backed social reforms,…

  • Business
  • Economy

Exclusive-Musk’s Neuralink valued at about $5 billion despite long road to market

The Cheap InvestorJune 5, 2023June 5, 20230

By Rachael Levy, Krystal Hu and Marisa Taylor (Reuters) – Elon Musk’s brain implant startup Neuralink, which was valued at…

  • Business
  • Health

Analysis-Stelara patent deal puts J&J back on path to $57 billion 2025 revenue forecast

The Cheap InvestorJune 5, 2023June 5, 20230

By Patrick Wingrove (Reuters) – Johnson & Johnson’s legal settlement with Amgen Inc to delay a biosimilar version of its…

  • Business
  • Health

UnitedHealth offers over $3 billion for home health firm Amedisys

The Cheap InvestorJune 5, 2023June 5, 20230

By Leroy Leo (Reuters) – UnitedHealth Group on Monday made a surprise $3.26 billion all-cash offer to acquire Amedisys Inc,…

  • Africa
  • Asia

UN body condemns U.S., others for treatment of Guantanamo inmate

The Cheap InvestorJune 5, 2023June 5, 20230

By Emma Farge GENEVA (Reuters) – The United States and several other countries have committed human rights violations against a…

  • Environment
  • Europe

Adulterated cider kills 16 in Russia, dozens sick

The Cheap InvestorJune 5, 2023June 5, 20230

(Reuters) -At least 16 people have died and dozens more have fallen ill after drinking adulterated cider in western Russia’s…

  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 62

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

  • US economic growth slows sharply in the fourth quarter
  • Trump to make new economic pitch in Georgia as prices stay high
  • AI pioneer Fei-Fei Li’s World Labs raises $1 billion in funding
  • Warsh may want a smaller Fed balance sheet, but that’s hard to achieve
  • Microsoft, Ericsson lead global tech alliance for digital trust
  • Cooling January inflation keeps Fed easing in play
  • US rate futures raise odds of Fed easing in June after inflation data
  • Air Canada sees surging overseas corporate travel following U.S. trade tensions
The Cheap Investor

The Cheap Investor

One Newspaper - News / Magazine WordPress Theme 2026.
Back To Top